Mereo BioPharma Group PLC ADR Dividends
The next dividend date for Mereo BioPharma Group PLC ADR has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Mereo BioPharma Group PLC ADR (MREO)
More About Mereo BioPharma Group PLC ADR
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.
Owning Mereo BioPharma Group PLC ADR Stock on the Dividend Date
If you own Mereo BioPharma Group PLC ADR stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Mereo BioPharma Group PLC ADR stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Mereo BioPharma Group PLC ADR stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Mereo BioPharma Group PLC ADR stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Mereo BioPharma Group PLC ADR dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Mereo BioPharma Group PLC ADR Dividends
You can contact us any time if you would like to ask questions about Mereo BioPharma Group PLC ADR dividends or anything else related to the stock market.